<SEC-DOCUMENT>0001193125-24-138936.txt : 20240515
<SEC-HEADER>0001193125-24-138936.hdr.sgml : 20240515
<ACCEPTANCE-DATETIME>20240515083032
ACCESSION NUMBER:		0001193125-24-138936
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20240515
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240515
DATE AS OF CHANGE:		20240515

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TEVA PHARMACEUTICAL INDUSTRIES LTD
		CENTRAL INDEX KEY:			0000818686
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-16174
		FILM NUMBER:		24947336

	BUSINESS ADDRESS:	
		STREET 1:		TEVA PHARMACEUTICAL INDUSTRIES LIMITED
		STREET 2:		124 DVORA HANEVI'A ST.
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6944020
		BUSINESS PHONE:		972 (3) 914-8213

	MAIL ADDRESS:	
		STREET 1:		TEVA PHARMACEUTICAL INDUSTRIES LIMITED
		STREET 2:		124 DVORA HANEVI'A ST.
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6944020
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d820660d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:teva="http://www.tevapharm.com/20240515" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityRegistrantName" name="dei:EntityRegistrantName" contextRef="duration_2024-05-15_to_2024-05-15">TEVA PHARMACEUTICAL INDUSTRIES LTD</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityTaxIdentificationNumber" name="dei:EntityTaxIdentificationNumber" contextRef="duration_2024-05-15_to_2024-05-15">00-0000000</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2024-05-15_to_2024-05-15" id="ixv-292">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2024-05-15_to_2024-05-15">0000818686</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="teva-20240515.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2024-05-15_to_2024-05-15"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000818686</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-05-15</xbrli:startDate> <xbrli:endDate>2024-05-15</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <ix:nonNumeric name="dei:DocumentType" contextRef="duration_2024-05-15_to_2024-05-15" id="ixv-303">8-K</ix:nonNumeric></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section 13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2024-05-15_to_2024-05-15" format="ixt:datemonthdayyearen" id="ixv-304">May 15, 2024</ix:nonNumeric></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <span style=" -sec-ix-hidden:Hidden_dei_EntityRegistrantName">TEVA PHARMACEUTICAL INDUSTRIES LIMITED</span> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2024-05-15_to_2024-05-15" format="ixt-sec:edgarprovcountryen" id="ixv-305">Israel</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2024-05-15_to_2024-05-15" id="ixv-306">001-16174</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"> <span style=" -sec-ix-hidden:Hidden_dei_EntityTaxIdentificationNumber">Not Applicable</span> </span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or Other Jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of Incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(IRS Employer<br/>Identification Number)</span></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top" colspan="5"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2024-05-15_to_2024-05-15" id="ixv-307">124 Dvora Hanevi&#8217;a Street</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2024-05-15_to_2024-05-15" id="ixv-308">Tel Aviv</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2024-05-15_to_2024-05-15" id="ixv-309">6944020</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCountry" contextRef="duration_2024-05-15_to_2024-05-15" format="ixt-sec:countrynameen" id="ixv-310">Israel</ix:nonNumeric></p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top" colspan="5"><span style="font-weight:bold">(Address of Principal Executive Offices, including Zip Code)</span></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:99%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">+<ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2024-05-15_to_2024-05-15" id="ixv-311">972</ix:nonNumeric>-<ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2024-05-15_to_2024-05-15" id="ixv-312">3-914-8213</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Registrant&#8217;s Telephone Number, including Area Code)</span></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not Applicable</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former Name or Former Address, if Changed Since Last Report)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><span style="font-style:italic">Copies of communications to: </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2024-05-15_to_2024-05-15" format="ixt-sec:boolballotbox" id="ixv-313">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2024-05-15_to_2024-05-15" format="ixt-sec:boolballotbox" id="ixv-314">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2024-05-15_to_2024-05-15" format="ixt-sec:boolballotbox" id="ixv-315">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2024-05-15_to_2024-05-15" format="ixt-sec:boolballotbox" id="ixv-316">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section 12(b) of the Act:</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br/>Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange<br/>on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2024-05-15_to_2024-05-15" id="ixv-317">American Depositary Shares, each representing one Ordinary Share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2024-05-15_to_2024-05-15" id="ixv-318">TEVA</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2024-05-15_to_2024-05-15" format="ixt-sec:exchnameen" id="ixv-319">New York Stock Exchange</ix:nonNumeric></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">Emerging Growth Company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2024-05-15_to_2024-05-15" format="ixt-sec:boolballotbox" id="ixv-320">&#9744;</ix:nonNumeric></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">ITEM&#8201;5.02&#8195;Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Departure of Mr.&#160;Eric Drap&#233;, Executive Vice President, Global Operations </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Mr.&#160;Eric Drap&#233;, Executive Vice President, Global Operations, will be leaving Teva Pharmaceutical Industries Ltd. (&#8220;Teva&#8221; or the &#8220;Company&#8221;). Mr.&#160;Drap&#233; will remain in his role until June&#160;3, 2024. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Appointment of Mr.&#160;Matthew Shields, Executive Vice President, Global Operations </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Mr.&#160;Matthew&#160;Shields has been appointed as Executive Vice President, Global Operations of Teva and a member of Teva Executive Management, effective June&#160;3, 2024. Mr.&#160;Shields will be based out of Teva&#8217;s U.S. headquarters. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Mr.&#160;Shields, age 50, is a manufacturing and supply chain leader with more than 25 years of experience in the biopharmaceuticals and animal health industries. Prior to joining Teva, Mr.&#160;Shields was the Senior Vice President for Manufacturing at Merck Animal Health (known as MSD Animal Health outside of the United States and Canada), which he joined in 2020. Prior to his time at Merck Animal Health, Mr.&#160;Shields was a senior leader at Sanofi from 2017 to 2020, first serving as Head of Engineering and Operational Excellence for Sanofi&#8217;s Biologics organization from 2017, and later serving as Global Head of Sanofi&#8217;s Specialty Care Manufacturing organization from 2017 to 2020, during which time he also oversaw the commissioning and startup of Sanofi&#8217;s first digitally enabled continuous manufacturing facility. From 2000 to 2017, Mr.&#160;Shields served at Amgen, holding a series of increasingly senior leadership roles, including Head of Global Raw Material Supplier Relationships, Executive Director and Plant Manager in Singapore, and Executive Director of Manufacturing. Mr.&#160;Shields received his undergraduate degree in Chemical Engineering and Materials Science Engineering from the University of Connecticut and a Master of Business Administration from Bryant University in Rhode Island. He currently serves on the board of the National Association of Manufacturers. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Mr.&#160;Shields will serve as Executive Vice President, Global Operations of Teva with an initial base salary of $825,000, with eligibility to be considered for an annual cash incentive with a target amount equal to 100% of Mr.&#160;Shields&#8217;s annual base salary, and for equity-based awards under the Company&#8217;s equity compensation plan. Mr.&#160;Shields is eligible to participate in employee benefit plans, including medical, disability, dental, life, 401(k) plan, deferred compensation and other programs. Mr.&#160;Shields will also receive a <span style="white-space:nowrap">sign-on</span> cash award of $200,000 and certain relocation benefits. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Upon termination by Teva (except for cases of gross or willful misconduct by Mr.&#160;Shields), Mr.&#160;Shields will be entitled to receive cash severance which equals to the product of nine times his monthly base salary and payment of certain costs associated with continued medical insurance for 18 months. Mr.&#160;Shields will also be entitled to receive an indemnity, in compensation of his undertaking not to compete with the Company for nine months following termination, paid on a monthly basis during these nine months, for a total amount which equals to nine times his monthly base salary. In the additional event that his employment is terminated by Teva, except for cases of gross or willful misconduct of Mr.&#160;Shields, within one year following certain change of control transactions and as a result thereof, Mr.&#160;Shields will be entitled to an additional lump sum cash payment of $1.5&#160;million. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Mr.&#160;Shields does not have any family relationships with any of the Company&#8217;s directors or executive officers and is not party to any transactions required to be disclosed under Item 404(a) of Regulation <span style="white-space:nowrap">S-K.</span> </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">ITEM&#8201;7.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Regulation FD Disclosure </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">On May&#160;15, 2024, Teva issued a press release announcing that Mr.&#160;Matthew Shields will be appointed as Executive Vice President, Global Operations. A copy of the press release is furnished as Exhibit 99.1 hereto and is incorporated by reference herein. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The information in this Item 7.01 and Exhibit 99.1 hereto is being furnished to the Securities and Exchange Commission (the &#8220;Commission&#8221;) and shall not be deemed &#8220;filed&#8221; for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;) nor shall it be deemed incorporated by reference in any filing made by the Company under the&#160;Securities Act&#160;or the Exchange Act, except as set forth by specific reference in such filing. </p> <p style="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&#160;</p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">ITEM&#8201;9.01 Financial Statements and Exhibits </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Exhibits </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:4%"/>
<td style="width:93%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit</p> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">No.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold">Description of Document</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d820660dex991.htm">Press release of the Company issued on May&#160;15, 2024. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document).</td></tr>
</table> <p style="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&#160;</p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">3 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:44%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:4%"/>

<td style="vertical-align:bottom"/>
<td style="width:5%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:44%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3"><span style="font-weight:bold">TEVA PHARMACEUTICAL INDUSTRIES LIMITED</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Date: May&#160;15, 2024</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Eli Kalif</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Name:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Eli Kalif</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Title:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Executive Vice President, Chief Financial Officer</td></tr>
</table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">4 </p>

</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d820660dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g820660dsp6.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TEVA ANNOUNCES APPOINTMENT OF MATTHEW SHIELDS TO EXECUTIVE VICE PRESIDENT, TEVA GLOBAL OPERATIONS
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>TEL AVIV, Israel, May</B><B></B><B>&nbsp;15, 2024, BUSINESS WIRE</B>&#150; Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today
announced the appointment of Matthew Shields as Executive Vice President of Teva Global Operations (TGO), the Company&#146;s manufacturing and supply division, effective June&nbsp;3, 2024. Mr.&nbsp;Shields succeeds Eric Drap&eacute;, who is leaving
after 11 years with the Company, including more than four years as Executive Vice President, Global Operations. Mr.&nbsp;Shields will be a member of Teva&#146;s Executive Leadership Team and report directly to President and CEO Richard Francis. He
will be based in Teva&#146;s U.S. headquarters in Parsippany, NJ. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Shields joins Teva with a track record over a
<FONT STYLE="white-space:nowrap">25-plus</FONT> year career in the global biopharmaceutical and animal health industries. As an engineer by trade, Mr.&nbsp;Shields brings significant experience at every stage of the manufacturing and supply process.
Most recently, Mr.&nbsp;Shields served as Senior Vice President for Animal Health Manufacturing for Merck, known as MSD Animal Health outside of the United States and Canada, where he oversaw <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">end-to-end</FONT></FONT> manufacturing, supply chain, procurement, and process development. Prior to Merck, he led Specialty Care Manufacturing, Engineering, and Operational Excellence for Sanofi. Mr.&nbsp;Shields spent
much of his early career at Amgen, where held a variety of leadership roles in Operations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Richard Francis, Teva&#146;s President and CEO stated:
&#147;I&#146;m thrilled to welcome a transformational leader of Matthew&#146;s caliber to the executive team at Teva. Matthew brings a wealth of experience in health operations that are critical to fulfilling our purpose by enabling Teva to execute
on our promises to patients and healthcare systems around the world. Matthew is ideally positioned to lead our TGO organization through the next phase of our Pivot to Growth journey.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Francis added: &#147;As we have intensified our efforts to best position Teva for future success through our Pivot to Growth strategy, Eric
Drap&eacute; has played a key role in strengthening our operations network. During his tenure leading TGO, the organization has made tremendous strides serving patients by standardizing processes, increasing agility, and improving our operating
margin. I would like to thank Eric for his many contributions to Teva and wish him all the best as he embarks on a new and exciting phase in his life.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Shields stated: &#147;Teva is clearly a company with incredible potential based on the early progress of its Pivot to Growth strategy, and its
tremendous heritage in manufacturing important medicines serving the needs of patients around the world. I&#146;m honored to take on this critical role, and eager to begin working with the talented team in Teva Global Operations, and my colleagues
across the Company, to deliver on our inspiring purpose.&#148; </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g820660dsp6.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Matthew Shields Bio </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Shields is a manufacturing and supply chain leader with more than 25 years of experience in the biopharmaceuticals and animal health industries.
He&#146;s held leadership roles at Merck Animal Health, Sanofi, and Amgen. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">He joins Teva from Merck Animal Health where he served as Senior Vice
President for Manufacturing with responsibility for supporting $5.6&nbsp;billion in annual sales. During his time at Merck, Mr.&nbsp;Shields also oversaw the Supply Chain, Procurement, and Process Development organizations. His leadership was
instrumental in navigating challenging global issues and business integration efforts, while driving improvements in the company&#146;s operations network and delivering significant savings. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Prior to Merck, Mr.&nbsp;Shields was a senior leader at Sanofi, first serving as Head of Engineering and Operational Excellence for the company&#146;s
Biologics organization. In that role, he led a lean transformation program resulting in substantial cost savings and operational efficiencies. Later he became Global Head of Sanofi&#146;s Specialty Care Manufacturing organization with a focus on
enabling the successful launches of Dupixent<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> and Praluent<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP>, while also overseeing the commissioning and startup of Sanofi&#146;s first
digitally enabled continuous manufacturing facility. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Shields spent a significant portion of his career with Amgen, holding series of
increasingly responsible leadership roles including Head of Global Raw Material Supplier Relationships, Executive Director&nbsp;&amp; Plant Manager in Singapore, and Executive Director of Manufacturing. Notable achievements include overseeing the
transition of Amgen&#146;s manufacturing of the future program from R&amp;D to Operations, the <FONT STYLE="white-space:nowrap">start-up</FONT> of its manufacturing site of the future in Singapore, and leading capacity and throughput improvements of
their large-scale biologics manufacturing facility in Rhode Island. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Shields received his undergraduate degree in Chemical Engineering&nbsp;&amp;
Materials Science Engineering from the University of Connecticut and an MBA from Bryant University in Rhode Island. He currently serves on the board of the National Association of Manufacturers. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Teva </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Teva Pharmaceutical Industries Ltd. (NYSE and
TASE: TEVA) is a global pharmaceutical leader with a category-defying portfolio, harnessing our generics expertise and stepping up innovation to continue the momentum behind the discovery, delivery, and expanded development of modern medicine. For
over 120 years, Teva&#146;s commitment to bettering health has never wavered. Today, the company&#146;s global network of capabilities enables its ~37,000 employees across 58 markets to push the boundaries of scientific innovation and deliver
quality medicines to help improve health outcomes of millions of patients every day. To learn more about how Teva is all in for better health, visit www.tevapharm.com. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Cautionary Note Regarding Forward-Looking Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on
management&#146;s current beliefs and expectations and are subject to substantial risks and uncertainties, both known and unknown, </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g820660dsp6.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
that could cause our future results, performance or achievements to differ significantly from that expressed or implied by such forward-looking statements. You can identify these forward-looking
statements by the use of words such as &#147;should,&#148; &#147;expect,&#148; &#147;anticipate,&#148; &#147;estimate,&#148; &#147;target,&#148; &#147;may,&#148; &#147;project,&#148; &#147;guidance,&#148; &#147;intend,&#148; &#147;plan,&#148;
&#147;believe&#148; and other words and terms of similar meaning and expression in connection with any discussion of future operating or financial performance. Important factors that could cause or contribute to such differences include risks
relating to: our business and operations in general, including our ability to attract, hire, integrate and retain highly skilled personnel; our ability to successfully compete in the marketplace, including our ability to successfully execute our
Pivot to Growth strategy, including to expand our innovative and biosimilar medicines pipeline and profitably commercialize the innovative medicines and biosimilar portfolio, whether organically or through business development, and to sustain and
focus our portfolio of generics medicines; and other factors discussed in this press release, in our quarterly report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the first quarter of 2024, and in our Annual Report on Form <FONT
STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2023, including in the sections captioned &#147;Risk Factors&#148;. Forward-looking statements speak only as of the date on which they are made, and we assume no obligation
to update or revise any forward-looking statements or other information contained herein, whether as a result of new information, future events or otherwise. You are cautioned not to put undue reliance on these forward-looking statements. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>IR Contacts </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">United States </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ran Meir (267) <FONT STYLE="white-space:nowrap">468-4475</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Israel </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Yael Ashman 972 (3)
<FONT STYLE="white-space:nowrap">914-8262</FONT> </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Media Contacts </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">United States </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Kelley Dougherty (973) <FONT
STYLE="white-space:nowrap">658-0237</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Israel </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Eden
Klein 972 (3) <FONT STYLE="white-space:nowrap">906-2645</FONT> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>teva-20240515.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 5/15/2024 8:50:19 AM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2023"
  xmlns:teva="http://www.tevapharm.com/20240515"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.tevapharm.com/20240515"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" namespace="http://xbrl.sec.gov/dei/2023" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2023/naics-2023.xsd" namespace="http://xbrl.sec.gov/naics/2023" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="teva-20240515_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="teva-20240515_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.tevapharm.com//20240515/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>teva-20240515_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 5/15/2024 8:50:19 AM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:type="locator" xlink:label="dei_EntityAddressCountry" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCountry_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Country</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCountry_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Country</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>teva-20240515_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 5/15/2024 8:50:19 AM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.tevapharm.com//20240515/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="teva-20240515.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.tevapharm.com//20240515/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:type="locator" xlink:label="dei_EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCountry" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g820660dsp6.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g820660dsp6.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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MO!O_ "4F7_\ <?\ ]1:YZF5_[Y1_[?\ _3<C[/K]S/K H * "@ H * "@ H
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MR_\ [C_^HM<]3*_]\H_]O_\ IN1]GU^YGU@4 % !0 4 % !0 4 % !0 4 %
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M7/4RO_?*/_;_ /Z;D?9]?N9]8% !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MCA&(V]L-T_7I^%)_D=-&7+[O1[+S_P"">O?"7CQ]H';']J^V,:+J-?1\&_\
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MC1=1R,>QK\BX.TXCR[I;ZQI_W*UCYO+5;&T5M;G_ /3<C[*K]Q/JPH * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H /Z?TH_0-OD?+GAS2_[&^,ZZ
M>J[8XM0UJ6 = +>ZT;4+J #V$<RC_@-?D>5X3ZCQTL,ERPA6Q4H+^Y4PU:I#
M[HR2^1\[0I^QS;V=K*,JC2\G3DU^9]1U^N'T04 % !0 4 % !0 4 % !0 4
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M_P!*LM.YU%>L= 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
&!0 4 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm139897284266096">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>May 15, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">TEVA PHARMACEUTICAL INDUSTRIES LTD<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">00-0000000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000818686<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 15,  2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">L3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-16174<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">124 Dvora Hanevi&#8217;a Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Tel Aviv<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">6944020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">972<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">3-914-8213<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">American Depositary Shares, each representing one Ordinary Share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">TEVA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
M" #/0Z]8]6X*?F,$  "U$   &    'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;(V8T6[B.!2&7\7*2'/53N*4 NT $@6Z@X:VJ- 9[:[VPB2&6)/86<= >?L]
M3FC":L()O2AQL/]\.>?XMTUOK_2O+.+<D/<DEEG?B8Q)[UTW"R*>L.R+2KF$
M;]9*)\Q 4V_<+-6<A?F@)'9]SVN["1/2&?3R>W,]Z*FMB87D<TVR;9(P?7C@
ML=KW'>I\W'@5F\C8&^Z@E[(-7W#SELXUM-Q2)10)EYE0DFB^[CM#>O_@M^R
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M:%0*CMQC)8QQ8K3^-8+)#^Q^ %!+ P04    " #/0Z]8'#AEZC\!   \ @
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M>::W=Y-[2:AU[D&P]_ :C1W-CQ^W_ %02P,$%     @ ST.O6"0>FZ*M
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M8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " #/0Z]87X+3]>\    K @  $0
M            @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " #/
M0Z]8F5R<(Q &  "<)P  $P              @ '- 0  >&PO=&AE;64O=&AE
M;64Q+GAM;%!+ 0(4 Q0    ( ,]#KUCU;@I^8P0  +40   8
M  " @0X(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " #/
M0Z]8GZ ;\+$"  #B#   #0              @ &G#   >&PO<W1Y;&5S+GAM
M;%!+ 0(4 Q0    ( ,]#KUB7BKL<P    !,"   +              "  8,/
M  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( ,]#KU@<.&7J/P$  #P"   /
M          "  6P0  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " #/0Z]8
M)!Z;HJT   #X 0  &@              @ '8$0  >&PO7W)E;',O=V]R:V)O
M;VLN>&UL+G)E;'-02P$"% ,4    " #/0Z]899!YDAD!  #/ P  $P
M        @ &]$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"
(   '%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1.1.u2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d820660d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tevapharm.com//20240515/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityRegistrantName -  d820660d8k.htm 7</Log>
  </Logs>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="d820660d8k.htm">d820660d8k.htm</File>
    <File>teva-20240515.xsd</File>
    <File>teva-20240515_lab.xml</File>
    <File>teva-20240515_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d820660d8k.htm": {
   "nsprefix": "teva",
   "nsuri": "http://www.tevapharm.com/20240515",
   "dts": {
    "inline": {
     "local": [
      "d820660d8k.htm"
     ]
    },
    "schema": {
     "local": [
      "teva-20240515.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/naics/2023/naics-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "teva-20240515_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "teva-20240515_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 4,
    "http://xbrl.sec.gov/dei/2023": 4
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "report": {
    "R1": {
     "role": "http://www.tevapharm.com//20240515/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2024-05-15_to_2024-05-15",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d820660d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2024-05-15_to_2024-05-15",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d820660d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.tevapharm.com//20240515/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.tevapharm.com//20240515/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.tevapharm.com//20240515/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.tevapharm.com//20240515/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.tevapharm.com//20240515/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.tevapharm.com//20240515/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://www.tevapharm.com//20240515/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "terseLabel": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.tevapharm.com//20240515/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.tevapharm.com//20240515/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.tevapharm.com//20240515/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.tevapharm.com//20240515/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.tevapharm.com//20240515/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.tevapharm.com//20240515/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.tevapharm.com//20240515/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.tevapharm.com//20240515/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.tevapharm.com//20240515/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.tevapharm.com//20240515/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.tevapharm.com//20240515/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.tevapharm.com//20240515/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.tevapharm.com//20240515/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.tevapharm.com//20240515/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.tevapharm.com//20240515/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001193125-24-138936-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-24-138936-xbrl.zip
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MX6U2D"M1+3M'#]!O2Z05[I>5=:!L *-EOW^\_CHI'BTN/RE:C"0-5%_($8T
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M TF]&.,RCPTDT_JA-60C;=]G 9J,!;#B&FV2+:%180527T4<Z52]E@@"U-=
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M;.;SS<;239W6D+-^9J74'B!8%"C]E %.=4F <UHT/S.N?X&\\3]02P,$%
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M&T#@9#%/EOJ6D6#7NI>+IZ,8#@8C1AWA*-'8@TBA_CZ \.(Y-4??R2/(W2@
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M U!+ 0(4 Q0    ( ,]#KU@I\4 $QA4  .)_   .              "  0
M  !D.#(P-C8P9#AK+FAT;5!+ 0(4 Q0    ( ,]#KUB;I*O?>Q   $PR   1
M              "  ?(5  !D.#(P-C8P9&5X.3DQ+FAT;5!+ 0(4 Q0    (
M ,]#KUAD/^Y1/@,  $\+   1              "  9PF  !T979A+3(P,C0P
M-3$U+GAS9%!+ 0(4 Q0    ( ,]#KU@\[DUG408  'I#   5
M  "  0DJ  !T979A+3(P,C0P-3$U7VQA8BYX;6Q02P$"% ,4    " #/0Z]8
MZNE3U[$$  !F*@  %0              @ &-,   =&5V82TR,#(T,#4Q-5]P
<<F4N>&UL4$L%!@     %  4 0 $  '$U      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>d820660d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="teva-20240515.xsd" xlink:type="simple"/>
    <context id="duration_2024-05-15_to_2024-05-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000818686</identifier>
        </entity>
        <period>
            <startDate>2024-05-15</startDate>
            <endDate>2024-05-15</endDate>
        </period>
    </context>
    <dei:EntityRegistrantName
      contextRef="duration_2024-05-15_to_2024-05-15"
      id="Hidden_dei_EntityRegistrantName">TEVA PHARMACEUTICAL INDUSTRIES LTD</dei:EntityRegistrantName>
    <dei:EntityTaxIdentificationNumber
      contextRef="duration_2024-05-15_to_2024-05-15"
      id="Hidden_dei_EntityTaxIdentificationNumber">00-0000000</dei:EntityTaxIdentificationNumber>
    <dei:AmendmentFlag contextRef="duration_2024-05-15_to_2024-05-15" id="ixv-292">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2024-05-15_to_2024-05-15"
      id="Hidden_dei_EntityCentralIndexKey">0000818686</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2024-05-15_to_2024-05-15" id="ixv-303">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2024-05-15_to_2024-05-15" id="ixv-304">2024-05-15</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2024-05-15_to_2024-05-15" id="ixv-305">L3</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2024-05-15_to_2024-05-15" id="ixv-306">001-16174</dei:EntityFileNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2024-05-15_to_2024-05-15" id="ixv-307">124 Dvora Hanevi&#x2019;a Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2024-05-15_to_2024-05-15" id="ixv-308">Tel Aviv</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode contextRef="duration_2024-05-15_to_2024-05-15" id="ixv-309">6944020</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCountry contextRef="duration_2024-05-15_to_2024-05-15" id="ixv-310">IL</dei:EntityAddressCountry>
    <dei:CityAreaCode contextRef="duration_2024-05-15_to_2024-05-15" id="ixv-311">972</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2024-05-15_to_2024-05-15" id="ixv-312">3-914-8213</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2024-05-15_to_2024-05-15" id="ixv-313">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2024-05-15_to_2024-05-15" id="ixv-314">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2024-05-15_to_2024-05-15" id="ixv-315">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2024-05-15_to_2024-05-15" id="ixv-316">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2024-05-15_to_2024-05-15" id="ixv-317">American Depositary Shares, each representing one Ordinary Share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2024-05-15_to_2024-05-15" id="ixv-318">TEVA</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2024-05-15_to_2024-05-15" id="ixv-319">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2024-05-15_to_2024-05-15" id="ixv-320">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
